Lamellar Ichthyosis Clinical Trials

Currently Enrolling

• Mayne Protocol 18-ICH-001: A Phase 2 randomized, multi-center, double-blind, vehicle controlled, 12 week, safety, efficacy & systemic exposure study followed by a 12 week open-label extension of CD5789 in adults and adolescents with autosomal recessive ichthyosis with lamellar scale.  |  Learn More »  |  Request to Join This Study »

View Other Clinical Trials

• Acne
• Actinic Keratoses
• Atopic Dermatitis (Eczema)
• Axillary Hyperhidrosis
• Bullous Pemphigoid
• Hidradenitis Suppurativa
• Lamellar Ichthyosis
• Psoriasis
• Prurigo Nodularis